Abstract
Intellectual property protection, including patents, is a critical factor underpinning investment and progress in the development of genetically modified foods. The GATT agreement made suggestions for the harmonization of patent laws and also made provisions for the avoidance of discrimination based on place of invention. However, plant and animal ‘varieties’ are currently not patentable. Much of the debate concerns what is meant by ‘variety’. There is also some debate currently concerning the morality of patenting living organisms. Much of the debate concerns risks, benefits and ethical issues, much of which is outside the scope of the patent system.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
